title: [Clinical study on comparison of tonifying kidney replenishing vitality and removing blood stasis and resolving mass in the treatment of prostatic hyperplasia].
abstract: 70 patients with prostatic hyperplasia were observed. Among them 34 cases were treated with the regime of tonifying Kidney-replenishing Vitality (TKRV) and the other 36 cases were treated with removing blood stasis and resolving mass (Xiao Jin Dan). The dysuria of the patients in both groups was improved after treatment. The results of the transrectal ultrasonotomography showed as follows: (1) The effect on the volume of residual urine: the average values of the TKRV group were 43.29 +/- 14.03 ml before treatment and 17.24 +/- 5.13 ml after treatment (P < 0.05), that of Xiao Jin Dan were 21.17 +/- 5.57 ml and 7.37 +/- 2.87 ml respectively (P < 0.01). (2) The effect on the size of the prostate gland: only 10 cases in the TKRV group were measured both before and after treatment, the average size of the prostate gland were 46.30 +/- 8.23 ml and 43.60 +/- 4.52 ml respectively (P < 0.05), and 4 cases were decreased in the size after treatment. 35 cases in Xiao Jin Dan group were measured before and after treatment and their size of prostate gland were 47.83 +/- 2.50 ml and 43.45 +/- 2.24 ml (P < 0.01) respectively. 27 out of the 35 cases were decreased in their size of prostate gland. The results showed that the therapeutic effect of Xiao Jin Dan was slightly better than that of the TKRV, which suggested that the prostatic hyperplasia was closely related to the syndrome of Kidney-Deficiency as well as to the syndrome of Blood Stasis. So it is important that we combined the reinforcement and elimination in the treatment of prostatic hyperplasia.
authors.affiliation: Huashan Hospital, Shanghai Medical University.
authors.forename: J W
authors.initials: JW
authors.lastname: Xie
authors.forename: Z Y
authors.initials: ZY
authors.lastname: Shen
authors.forename: W J
authors.initials: WJ
authors.lastname: Wang
mesh_terms: D000368:Aged; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000000981:diagnostic imaging / Q000473:pathology; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000473:pathology; D014463:Ultrasonography
chemical_list: D004365:Drugs, Chinese Herbal